LIVE NOW: FDA Vaccines and Related Biological Products Advisory Committee Holds Meeting

The FDA Vaccines and Related Biological Products Advisory Committee holds a meeting at 9 a.m. ET on March 12 to discuss and make recommendations on the strain composition of influenza virus vaccines for use in the United States during the 2026–2027 influenza season.